KAT8 and cancer: Consistently, independent studies have reported MOF to be downregulated in a panel of cancer types including breast cancer 86, ovarian epithelial cancer 87, colorectal carcinoma 88, gastric cancer 88, 89, hepatocellular carcinoma 90, and medulloblastoma 86.